We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-17.55%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$28.5M
AUM Growth
-$42.5M
Cap. Flow
-$44.1M
Cap. Flow %
-154.82%
Top 10 Hldgs %
79.95%
Holding
53
New
16
Increased
1
Reduced
7
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 33.11%
2 Communication Services 2.79%
3 Technology 2.11%
4 Materials 1.01%
5 Consumer Staples 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHEKZ
26
DELISTED
Check-Cap Ltd. Series C Warrant
CHEKZ
$23K 0.08%
136,364
SGLBW
27
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$9K 0.03%
48,100
ARTLW
28
DELISTED
Artelo Biosciences, Inc. Warrant
ARTLW
$4K 0.01%
65,000
PSTVZ
29
DELISTED
PLUS THERAPEUTICS, Inc. Series S Warrant
PSTVZ
$2K 0.01%
259,200
BNTCW
30
DELISTED
Benitec Biopharma Limited
BNTCW
$2K 0.01%
50,000
CREXW
31
DELISTED
Creative Realities, Inc. Warrant
CREXW
$1K ﹤0.01%
15,000
MDGSW
32
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$1K ﹤0.01%
63,286
AMRHW
33
DELISTED
Ameri Holdings, Inc. Warrant
AMRHW
$1K ﹤0.01%
85,231
-13,469
-14% -$391
ABEO icon
34
Abeona Therapeutics
ABEO
$369M
-209,095
Closed -$17.1M
ACHV icon
35
Achieve Life Sciences
ACHV
$647M
-58,497
Closed -$620K
AEHL icon
36
Antelope Enterprise Holdings
AEHL
$9.17M
-28
Closed -$136K
BCRX icon
37
BioCryst Pharmaceuticals
BCRX
$2.35B
-148,952
Closed -$514K
LPCN icon
38
Lipocine
LPCN
$17.4M
-16,027
Closed -$105K
MNKD icon
39
MannKind Corp
MNKD
$1.27B
-3,705,310
Closed -$4.78M
NAK
40
Northern Dynasty Minerals
NAK
$779M
-3,280,759
Closed -$1.4M
FLNA
41
Filana Therapeutics
FLNA
$46.4M
-452,246
Closed -$2.35M
SCYX icon
42
SCYNEXIS
SCYX
$37M
-8,046
Closed -$586K
AUMN
43
DELISTED
Golden Minerals Company
AUMN
-40,850
Closed -$317K
BCEL
44
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-83,001
Closed -$1.28M
HEXO
45
DELISTED
HEXO Corp. Common Shares
HEXO
-41,586
Closed -$3.7M
AMPE
46
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-1,855
Closed -$324K
UUUU.WS
47
DELISTED
Energy Fuels Inc.
UUUU.WS
$0 ﹤0.01%
277,777
NBRV
48
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-13,868
Closed -$4.58M
BVXVW
49
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
-72,800
Closed -$189K
FPAYW
50
DELISTED
FlexShopper, Inc. Warrants
FPAYW
-38,443
Closed -$58K

Similar funds

CVI Holdings's Q1 2020 Portfolio in Review

As of Q1 2020, CVI Holdings held 53 positions worth $28.5M, down 60% from $71M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

CVI Holdings withdrew a net $44.1M in Q1 2020, closing 16 positions and reducing 7 holdings. Its most notable exit was Abeona Therapeutics, an estimated $17.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 67% a quarter earlier, followed by Communication Services and Technology.

Against the trend, CVI Holdings opened a new position in Yunhong International Unit worth $3.33M.

  • CVI Holdings's largest Q1 2020 buy was Yunhong International Unit: 350,000 shares worth $3.33M.
  • CVI Holdings added most to Farmmi Inc in Q1 2020, an estimated $190K increase.
  • CVI Holdings's biggest Q1 2020 reduction was Amyris Inc., cutting an estimated $5.74M.
  • CVI Holdings fully exited Abeona Therapeutics in Q1 2020, selling an estimated $17.1M.
  • CVI Holdings's ten largest holdings make up 80% of its $28.5M portfolio in Q1 2020.
  • CVI Holdings opened 16 new positions and closed 16 in Q1 2020.
  • CVI Holdings's portfolio value fell 60% quarter-over-quarter to $28.5M.

Based on CVI Holdings's 13F filing for Q1 2020, filed 15 May 2020.